Literature DB >> 7259931

Total and free serum haloperidol levels in schizophrenic patients and the effect of age thioridazine and fatty acid on haloperidol-serum protein binding in vitro.

F J Rowell, S M Hui, A F Fairbairn, D Eccleston.   

Abstract

1 Using radioimmunoassays, steady-state levels of total and free haloperidol (obtained by ultrafiltration and dialysis) have been determined in twenty-two patients on long term treatment receiving doses from 3 to 45 mg per day. 2 For the group, both total serum concentration and free drug concentration showed significant correlations (P less than 0.001) with daily dose. 3 No significant correlation was observed between age of the patient and percentage free haloperidol in serum. 4 In vitro experiments using sera from twenty-three healthy volunteers showed significant negative correlations (P less than 0.01) between age and percentage free haloperidol. 5 Thioridazine and oleic acid significantly enhanced the percentage of free haloperidol in normal human sera in vitro.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7259931      PMCID: PMC1401662          DOI: 10.1111/j.1365-2125.1981.tb01135.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

1.  Drug therapy of tardive dyskinesia.

Authors:  R M Kobayashi
Journal:  N Engl J Med       Date:  1977-02-03       Impact factor: 91.245

Review 2.  Receptors, neurotransmitters and drug responses.

Authors:  S H Snyder
Journal:  N Engl J Med       Date:  1979-03-01       Impact factor: 91.245

3.  Binding of thioridazine and thioridazine metabolites to serum proteins in psychiatric patients.

Authors:  G Nyberg; R Axelsson; E Mårtensson
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

4.  Factors predisposing to drug-induced neurologic effects.

Authors:  G E Crane
Journal:  Adv Biochem Psychopharmacol       Date:  1974

5.  Nutrition and the brain.

Authors:  J D Fernstrom; R J Wurtman
Journal:  Sci Am       Date:  1974-02       Impact factor: 2.142

6.  Concentration-dependent effects of fatty acids on warfarin binding to albumin.

Authors:  G Wilding; R C Feldhoff; E S Vesell
Journal:  Biochem Pharmacol       Date:  1977-06-15       Impact factor: 5.858

7.  Pharmacokinetic studies on haloperidol in man.

Authors:  A Forsman; R Ohman
Journal:  Curr Ther Res Clin Exp       Date:  1976-09

8.  Long chain fatty acid binding to human plasma albumin.

Authors:  J D Ashbrook; A A Spector; E C Santos; J E Fletcher
Journal:  J Biol Chem       Date:  1975-03-25       Impact factor: 5.157

9.  Plasma protein binding interaction between phenytoin and valproic acid in vitro.

Authors:  A Monks; S Boobis; J Wadsworth; A Richens
Journal:  Br J Clin Pharmacol       Date:  1978-12       Impact factor: 4.335

10.  Decreased plasma protein binding of phenytoin in patients on valproic acid.

Authors:  R Dahlqvist; O Borgå; A Rane; Z Walsh; F Sjöqvist
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

View more
  9 in total

Review 1.  Age-related changes in protein binding of drugs: implications for therapy.

Authors:  M K Grandison; F D Boudinot
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

Review 2.  Pharmacokinetics of haloperidol: an update.

Authors:  S Kudo; T Ishizaki
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

Review 3.  Plasma protein binding of drugs in the elderly.

Authors:  S M Wallace; R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

4.  Effect of age and sex on the plasma binding of acidic and basic drugs.

Authors:  R K Verbeeck; J A Cardinal; S M Wallace
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Structure-based design of haloperidol analogues as inhibitors of acetyltransferase Eis from Mycobacterium tuberculosis to overcome kanamycin resistance.

Authors:  Ankita Punetha; Keith D Green; Atefeh Garzan; Nishad Thamban Chandrika; Melisa J Willby; Allan H Pang; Caixia Hou; Selina Y L Holbrook; Kyle Krieger; James E Posey; Tanya Parish; Oleg V Tsodikov; Sylvie Garneau-Tsodikova
Journal:  RSC Med Chem       Date:  2021-10-05

6.  Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part I.

Authors:  R Miller
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

Review 7.  Pharmacokinetics of haloperidol.

Authors:  J S Froemming; Y W Lam; M W Jann; C M Davis
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447

8.  Nonlinear relationship between circulating concentrations of reduced haloperidol and haloperidol: evaluation of possible mechanisms.

Authors:  D W Eyles; T J Stedman; S M Pond
Journal:  Psychopharmacology (Berl)       Date:  1994-10       Impact factor: 4.530

9.  The Binding Effect of Proteins on Medications and Its Impact on Electrochemical Sensing: Antipsychotic Clozapine as a Case Study.

Authors:  George E Banis; Thomas Winkler; Patricia Barton; Sheryl E Chocron; Eunkyoung Kim; Deanna L Kelly; Gregory F Payne; Hadar Ben-Yoav; Reza Ghodssi
Journal:  Pharmaceuticals (Basel)       Date:  2017-08-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.